| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Gallic Acid | AGE Products | 3 | PM | 33304826 | 📋 | Resveratrol, curcumin and gallic acid attenuate glyoxal-induced damage to rat renal cells |
| Gallic Acid | AGE Products | 1 | PM | 29432842 | 📋 | Diet With High Content of Advanced Glycation End Products Induces Systemic Inflammation and Weight Gain in Experimental Mice: Protective Role of Curcumin and Gallic Acid |
| Gallic Acid | AGE Products | 2 | PM | 26242637 | 📋 | Anti-Glycation Effects of Pomegranate (Punica granatum L.) Fruit Extract and Its Components in Vivo and in Vitro |
| Gallic Acid | AGE Products | 5 | PM | 24309158 | 📋 | Regulatory mechanism of gallic acid against advanced glycation end products induced cardiac remodeling in experimental rats |
| Gallic Acid | AGE Products | 4 | PM | 24062022 | 📋 | Inhibitory effect of gallic acid on advanced glycation end products induced up-regulation of inflammatory cytokines and matrix proteins in H9C2 (2-1) cells |
| Gallic Acid | Diabetes Type 2 | 5 | PM | 35052597 | 📋 | Gallic Acid Improves Diabetic Steatosis by Downregulating MicroRNA-34a-5p through Targeting NFE2L2 Expression in High-Fat Diet-Fed db/db Mice |
| Gallic Acid | Diabetes Type 2 | 2 | PM | 34100378 | 📋 | Hepatoprotective effect of gallic acid against type 2-induced diabetic liver injury in male rats through modulation of fetuin-A and GLP-1 with involvement of ERK1/2/NF-κB and Wnt1/β-catenin signaling pathways |
| Gallic Acid | Diabetes Type 2 | 3 | PM | 30021345 | 📋 | Modulation of hyperglycemia and dyslipidemia in experimental type 2 diabetes by gallic acid and p-coumaric acid: The role of adipocytokines and PPARγ |
| Gallic Acid | Diabetes Type 2 | 1 | PM | 29193677 | 📋 | Gallic Acid Improves Health-Associated Biochemical Parameters and Prevents Oxidative Damage of DNA in Type 2 Diabetes Patients: Results of a Placebo-Controlled Pilot Study |
| Gallic Acid | Diabetes Type 2 | 4 | PM | 25445038 | 📋 | Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway |
| Gallic Acid | Diabetes Type 2 | 7 | PM | 19610036 | 📋 | Gallic acid protects RINm5F beta-cells from glucolipotoxicity by its antiapoptotic and insulin-secretagogue actions |
| Gallic Acid | Glucose Metabolism Disorder | 1 | PM | 24219649 | 📋 | Gallic acid improves glucose tolerance and triglyceride concentration in diet-induced obesity mice |
| Gallic Acid | Hyperglycemia | 1 | PM | 31979987 | 📋 | Can gallic acid potentiate the antihyperglycemic effect of acarbose and metformin? Evidence from streptozotocin-induced diabetic rat model |
| Gallic Acid | Hyperlipidemia | 1 | PM | 32401050 | 📋 | New insights into the in vitro, in situ and in vivo antihyperglycemic mechanisms of gallic acid and p-coumaric acid |
| Gallic Acid | Insulin Resistance | 3 | PM | 37255787 | 📋 | Ameliorative effects of gallic acid on GLUT-4 expression and insulin resistance in high fat diet-induced obesity animal model mice, Mus musculus |
| Gallic Acid | Insulin Resistance | 2 | PM | 31841748 | 📋 | Gallic acid regulates adipocyte hypertrophy and suppresses inflammatory gene expression induced by the paracrine interaction between adipocytes and macrophages in vitro and in vivo |
| Gallic Acid | Insulin Resistance | 1 | PM | 25445038 | 📋 | Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway |
| Gallic Acid | Metabolic Disorders | 2 | PM | 37255787 | 📋 | Ameliorative effects of gallic acid on GLUT-4 expression and insulin resistance in high fat diet-induced obesity animal model mice, Mus musculus |
| Gallic Acid | Metabolic Disorders | 1 | PM | 33643038 | 📋 | Gallic Acid Ameliorated Impaired Lipid Homeostasis in a Mouse Model of High-Fat Diet-and Streptozotocin-Induced NAFLD and Diabetes through Improvement of β-oxidation and Ketogenesis |
| Gallic Acid | Metabolic Syndrome | 1 | PM | 32780904 | 📋 | Gallic acid improves recognition memory and decreases oxidative-inflammatory damage in the rat hippocampus with metabolic syndrome |
| Gallic Acid | Mitochondrial Dysfunction | 2 | PM | 34715756 | 📋 | Gallic acid inhibits celecoxib-induced mitochondrial permeability transition and reduces its toxicity in isolated cardiomyocytes and mitochondria |
| Gallic Acid | Mitochondrial Dysfunction | 1 | PM | 33668647 | 📋 | Rutin and Gallic Acid Regulates Mitochondrial Functions via the SIRT1 Pathway in C2C12 Myotubes |
| Gallic Acid | Obesity | 5 | PM | 38788813 | 📋 | Effects of gallic acid and physical training on liver damage, force, and anxiety in obese mice: Hepatic modulation of Sestrin 2 (SESN2) and PGC-α expression |
| Gallic Acid | Obesity | 4 | PM | 37536400 | 📋 | Gallic Acid as a Sestrin (SESN2) activator and potential obesity therapeutic agent: a molecular docking study |
| Gallic Acid | Obesity | 1 | PM | 31841748 | 📋 | Gallic acid regulates adipocyte hypertrophy and suppresses inflammatory gene expression induced by the paracrine interaction between adipocytes and macrophages in vitro and in vivo |
| Gallic Acid | Obesity | 2 | PM | 30039436 | 📋 | Gallic acid, a common dietary phenolic protects against high fat diet induced DNA damage |
| Gallic Acid | Obesity | 3 | PM | 22508359 | 📋 | Antiobesity effects of Chinese black tea (Pu-erh tea) extract and gallic acid |
| Gallic Acid | Overweight | 1 | PM | 29432842 | 📋 | Diet With High Content of Advanced Glycation End Products Induces Systemic Inflammation and Weight Gain in Experimental Mice: Protective Role of Curcumin and Gallic Acid |
| Gallic Acid | Postprandial Hyperglycemia | 1 | PM | 33988204 | 📋 | Inhibition of the intestinal postprandial glucose transport by gallic acid and gallic acid derivatives |
